| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 4, 2025 |
| Accession Number: | 0001104659-25-054925 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/4/2023 | Underperform → Mkt Perform | Bernstein | |
| 11/2/2022 | $1.50 | Underperform | Bernstein |
| 10/26/2022 | Sell → Hold | Canaccord Genuity | |
| 6/8/2022 | Market Perform → Underperform | BMO Capital Markets | |
| 3/22/2022 | Equal Weight → Underweight | Barclays | |
| 3/1/2022 | $14.00 → $9.00 | Equal-Weight | Barclays |
| 2/18/2022 | $9.60 → $11.00 | Neutral | Cantor Fitzgerald |
| 12/22/2021 | Neutral → Underperform | BofA Securities |
Canada cannabis revenue increased 4% in Q4 FY2025 year-over-year, led by 13% growth in Canada medical cannabis Reduced total debt by $293 million or 49% during FY2025 Refined strategy, focus and organizational structure expected to accelerate growth in global medical cannabis and improve commercial execution in Canada adult-use cannabis Additional cost reduction initiatives identified and initiated in Q4 FY2025 are expected to deliver at least $20 million in annualized savings over the next 12-18 months Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC) today announced its financial results for the fourth quarter ended March 31, 2025 ("Q4 FY2025") a
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED, NASDAQ:CGC) will release its financial results for the fourth quarter and fiscal year 2025 ended March 31, 2025, before financial markets open on May 30, 2025. Following the release of its fourth quarter and fiscal year 2025 financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO and Judy Hong, CFO on May 30, 2025, at 10 AM Eastern Time (ET). Webcast Information A live audio webcast will be available at: https://onlinexperiences.com/Launch/QReg/ShowUUID=1235414F-AB39-4A0B-871E-B1885B487ACD Replay Information A replay will be accessible by webcast until 11:59 PM ET on August 28, 2025 at:
Offerings reflect a focused format strategy in Canada's adult-use market Vapes, high-THC flower, pre-roll joints, and edibles introduced across core brands Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (NASDAQ:CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched a series of product innovations targeting Canada's fastest-growing adult-use categories.1 The lineup reflects a focused strategy built around four high-demand formats: vapes, high-THC flower, pre-rolls (including infused), and edibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
4 - Canopy Growth Corp (0001737927) (Issuer)
Bernstein upgraded Canopy Growth from Underperform to Mkt Perform
Bernstein initiated coverage of Canopy Growth with a rating of Underperform and set a new price target of $1.50
Canaccord Genuity upgraded Canopy Growth from Sell to Hold
424B7 - Canopy Growth Corp (0001737927) (Filer)
424B5 - Canopy Growth Corp (0001737927) (Filer)
EFFECT - Canopy Growth Corp (0001737927) (Filer)